Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Published in: Cardiovascular Drugs and Therapy 1/2011

01-02-2011

President’s Page

Author: Juan-Carlos Kaski

Published in: Cardiovascular Drugs and Therapy | Issue 1/2011

Login to get access

Excerpt

During 2009 and 2010, the presidency of Jay Cohn gave a new impetus to the ISCP with a newly designed website (www.​iscpcardio.​org), a successful meeting in Beijing—organized in collaboration with Hu Dayi, ISCP governor for China and President of the Chinese Society of Cardiology—and the creation of several educational committees involving governors from different countries around the world. Over 500 new website members were recruited during this period and the Society’s Newsletter was developed under the editorship of Lisa Demos and John McNeil, from Melbourne. …
Metadata
Title
President’s Page
Author
Juan-Carlos Kaski
Publication date
01-02-2011
Publisher
Springer US
Published in
Cardiovascular Drugs and Therapy / Issue 1/2011
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1007/s10557-010-6276-2

Other articles of this Issue 1/2011

Cardiovascular Drugs and Therapy 1/2011 Go to the issue

OriginalPaper

Blockade of the Renin-Angiotensin System Ameliorates Apelin Production in 3T3-L1 Adipocytes

OriginalPaper

Clinical Trials Update AHA Congress 2010

OriginalPaper

Long-Term Efficacy of Adding Fenofibric Acid to Moderate-Dose Statin Therapy in Patients with Persistent Elevated Triglycerides

OriginalPaper

Pre-treatment with a DPP-4 Inhibitor is Infarct Sparing in Hearts from Obese, Pre-diabetic Rats

OriginalPaper

Evaluation of the Functional Status Questionnaire in Heart Failure: A Sub-study of the Second Cardiac Insufficiency Bisoprolol Survival Study (CIBIS-II)

OriginalPaper

AMP-Activated Protein Kinase Inhibits Homocysteine-Induced Dysfunction and Apoptosis in Endothelial Progenitor Cells

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits